Radiolabeling and in vivo evaluation of [11C]AGH-44: a potential lead structure to develop a positron emission tomography radioligand for the 5-HT7 receptor
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Radiolabeling and in vivo evaluation of [11C]AGH-44 : a potential lead structure to develop a positron emission tomography radioligand for the 5-HT7 receptor. / L’Estrade, Elina T.; Petersen, Ida N.; Xiong, Mengfei; Hogendorf, Adam S.; Hogendorf, Agata; Kristensen, Jesper L.; Kjær, Andreas; Bojarski, Andrzej J.; Erlandsson, Maria; Ohlsson, Tomas; Knudsen, Gitte M.; Herth, Matthias M.
In: Journal of Radioanalytical and Nuclear Chemistry, Vol. 322, No. 2, 01.11.2019, p. 847-851.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Radiolabeling and in vivo evaluation of [11C]AGH-44
T2 - a potential lead structure to develop a positron emission tomography radioligand for the 5-HT7 receptor
AU - L’Estrade, Elina T.
AU - Petersen, Ida N.
AU - Xiong, Mengfei
AU - Hogendorf, Adam S.
AU - Hogendorf, Agata
AU - Kristensen, Jesper L.
AU - Kjær, Andreas
AU - Bojarski, Andrzej J.
AU - Erlandsson, Maria
AU - Ohlsson, Tomas
AU - Knudsen, Gitte M.
AU - Herth, Matthias M.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - AGH-44 is described as a selective low-basicity serotonin 7 receptor (5-HT7R) agonist. In this paper, we evaluate if AGH-44 can act as a lead structure to develop a 5-HT7R selective positron emission tomography (PET) tracer. 11C-labeling of AGH-44 succeeded in a two-step, one-pot procedure in good yields. Subsequent PET studies showed that [11C]AGH-44 displays low blood–brain-barrier passage in Long–Evans rats. Moreover, [11C]AGH-44 brain accumulation showed to be independent on permeability glycoprotein (P-gp) efflux inhibition. Results from biodistribution and metabolism studies could neither explain the observed low brain uptake. As such, we believe that this scaffold is not an optimal starting point to develop a 5-HT7R selective PET tracer.
AB - AGH-44 is described as a selective low-basicity serotonin 7 receptor (5-HT7R) agonist. In this paper, we evaluate if AGH-44 can act as a lead structure to develop a 5-HT7R selective positron emission tomography (PET) tracer. 11C-labeling of AGH-44 succeeded in a two-step, one-pot procedure in good yields. Subsequent PET studies showed that [11C]AGH-44 displays low blood–brain-barrier passage in Long–Evans rats. Moreover, [11C]AGH-44 brain accumulation showed to be independent on permeability glycoprotein (P-gp) efflux inhibition. Results from biodistribution and metabolism studies could neither explain the observed low brain uptake. As such, we believe that this scaffold is not an optimal starting point to develop a 5-HT7R selective PET tracer.
KW - 5-HT
KW - AGH-44
KW - Carbon-11
KW - PET
U2 - 10.1007/s10967-019-06687-3
DO - 10.1007/s10967-019-06687-3
M3 - Journal article
AN - SCOPUS:85074379944
VL - 322
SP - 847
EP - 851
JO - Journal of Radioanalytical and Nuclear Chemistry
JF - Journal of Radioanalytical and Nuclear Chemistry
SN - 0236-5731
IS - 2
ER -
ID: 231211017